Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment

Intestinal steroid refractory acute graft-versus-host disease (SR-aGVHD) is the major cause of mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT). This retrospective cohort study aimed to identify the relationship between different steroid decreasing velocity and therapeutic...

Full description

Bibliographic Details
Main Authors: Cong Cheng, Dao-Xing Deng, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yu-Qian Sun, Xiao-Jun Huang, Xiao-Dong Mo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
steroid refractory
acute graft-versus-host disease
basiliximab
steroid decrease protocol
hematopoietic stem cell transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1390438/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1390438/full

Similar Items